Author

Carl W. Greiner

Observed names: C Greiner, C. Greiner, C.W. Greiner, Carl Greiner, Carl W Greiner

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5005138310

Predicting PBSC harvest failure using circulating CD34 levels: developing target-based cutoff points for early intervention

2010 · S Sinha, D Gastineau, et al. · Bone Marrow Transplantation · 66

Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma

2006 · Svetomir N Markovic, Allan B Dietz, et al. · Journal of Translational Medicine · 29

Infusion technique of hematopoietic progenitor cells and related adverse events (CME)

2014 · Sudhanshu B. Mulay, Carl W. Greiner, et al. · Transfusion · 25

Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanoma

2004 · A.B. Dietz, D.J. Padley, et al. · Cytotherapy · 21

Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection target

2006 · R Katipamula, L F Porrata, et al. · Bone Marrow Transplantation · 15

Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy

2003 · D.J. Padley, C.W. Greiner, et al. · Cytotherapy · 15

The immunome of mobilized peripheral blood stem cells is predictive of long-term outcomes and therapy-related myeloid neoplasms in patients with multiple myeloma undergoing autologous stem cell transplant

2023 · Saurabh Zanwar, Eapen K. Jacob, et al. · Blood Cancer Journal · 8

The Peripheral Blood Stem Cell Immunome Demonstrates Abnormal Immune Effector Cells Early in the Disease Course of Multiple Myeloma and Contributes to Inferior Outcomes and Secondary Myeloid Neoplasms

2023 · Saurabh Zanwar, Eapen K. Jacob, et al. · Blood · 2

Predicting Poor Peripheral Blood Stem Cell Mobilization in Multiple Myeloma (MM) Using Initial Peripheral CD34 Counts: Developing Target-Based Cut-Points for Early Intervention.

2009 · Shirshendu Sinha, Dennis A. Gastineau, et al. · Blood · 2

Increasing use of CAR‐T therapy occurs in conjunction with decreasing stem cell transplants with stable resource usage over a 6‐year period: Resource utilization implications

2025 · Aswath P. Chandrasekar, Margret A. DiGuardo, et al. · Transfusion

Comparable Outcomes with or without Routine Granulocyte Growth Factor Support Following Autologous Peripheral Blood Stem Cell Transplantation (PBSCT): A Single Center Experience.

2009 · Harris V. Naina, Shaji Kumar, et al. · Blood

Predicting Poor Peripheral Blood Stem Cell Mobilization Using Initial Peripheral CD34 Counts in Patients with Lymphoma.

2009 · Shirshendu Sinha, Shaji Kumar, et al. · Blood

Procedural Apheresis Instrumentation Algorithm Minimizes Platelets Loss during Peripheral Blood Stem Cells Collection.

2006 · Elie M. Richa, Edwin A. Burgstaler, et al. · Blood

Immunotherapy of malignant melanoma using a dendritic cell-amplified tumor RNA vaccine: A phase I study

2005 · A. B. Dietz, S. Markovic, et al. · Journal of Clinical Oncology

Works count: 15

Citation count: 183

H-index: 7

I10-index: 6